Business Context and Reporting Period
This Form 8-K filing by Healthcare Trust of America, Inc. (NYSE: HTA) and Healthcare Trust of America Holdings, LP reports a material definitive agreement entered into on November 1, 2013. The filing replaces a prior equity distribution agreement dated January 7, 2013.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the reporting period. The primary financial metric disclosed is the authorization of an equity offering with an aggregate offering price of up to $300 million. The terminated prior agreement had $4.7 million of shares that could have been issued.
Material Changes
- Equity Distribution Agreement: Entered into a new agreement with Wells Fargo Securities, LLC to sell Class A common stock from time to time.
- Termination of Prior Agreement: The previous agreement dated January 7, 2013, was terminated concurrently with the new agreement.
- Offering Mechanism: Sales are anticipated to be made primarily through "at-the-market" offerings on the New York Stock Exchange or through market makers, as well as negotiated transactions.
Guidance, Outlook, and Management Commentary
Management intends to use the proceeds from the offering for general corporate purposes, including working capital and investment in real estate. Additionally, a portion of the proceeds may be used to pay certain outstanding long-term debt obligations. The stock will be offered under the company's effective Registration Statement on Form S-3 (File No. 333-185668). The filing text does not provide specific forward-looking guidance on earnings or operational metrics.
Investor Verification Checklist
- Verify the terms of the Equity Distribution Agreement attached as Exhibit 1.1.
- Confirm the current outstanding long-term debt obligations to assess the potential impact of debt repayment using offering proceeds.
- Monitor the volume and pricing of shares sold under the "at-the-market" program to evaluate dilution effects.
- Review the effective Registration Statement on Form S-3 (File No. 333-185668) for additional offering details.